- Deloitte and Rady’s Children’s Institute for Genomic Medicine (RCIGM) announced an innovative new project to explore the use of unmanned aircraft systems (UAS) known as drones to deliver genomic samples to the laboratory.- This approach seeks to cut down on ground traffic delays by flying genomic testing specimens to the lab, cutting the time needed to get results back to acutely ill babies and children.- The project is in the planning stages; Deloitte and RCIGM are working in coordination
Read More
genomic precision medicine
Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database
uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 million in Series C funding. The round was led by OS Fund, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. Now, uBiome is mining its database (the world's largest human microbiome database) to discover new therapeutic targets, with an initial focus on
Read More
Report: Precision Medicine Market Share to Cross $96B by 2024
The Precision Medicine Market size is set to exceed $96 billion dollars by 2024; according to a new research report by Global Market Insights. The new report reveals the rising prevalence of cancer across the globe fueling the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size.Advancement in cancer biology coupled with increased funding for cancer research will fuel industry
Read More
Akouos Raises $50M to Advance Precision Medicine for Hearing Disorders
Akouos, a Boston, MA-based precision genetic medicine company developing gene therapies that restore and preserve hearing has raised $50 million in Series A funding co-led by 5AM Ventures and New Enterprise Associates (NEA) with participation from existing investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund. The company plans to use the funding round to advance its lead program to first-in-human clinical trials and bolster its
Read More
Roche Acquires Rest of Foundational Medicine for $2.4B to Enhance Precision Medicine
Roche, today announced it has acquire all of the outstanding shares in Foundation Medicine that is not already owned by Roche and its affiliates for $2.4B, representing $137 per share. Together, the companies will leverage expertise in genomics and molecular information to enhance the development of perdsonalized medicines and care for patients with cancer.Foundation Medicine, based in Cambridge, Massachusetts, is a market leading molecular information company dedicated to a transformation in
Read More
Cytox Collaborates with Mayo Clinic to Develop New Algorithms to Evaluate Genetic Based Approaches for Assessing Alzheimer’s Risk
Cytox, a precision medicine company focused on commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s has entered into a research collaboration with Mayo Clinic to test current and develop new proprietary algorithms relating to the diagnosis and prognosis of Alzheimer’s disease. Under the agreement Cytox will assess genetic risk for developing Alzheimer’s disease using its current commercially available approaches developed to run on the
Read More
Cedars-Sinai, Emulate Partner on ‘Patient-on-a-Chip’ Program to Predict Disease Treatments
Scientists at Cedars-Sinai and Boston-based digital health startup Emulate are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant—a new approach to advance precision medicine.Researchers know that people respond differently to foods, drugs, and chemicals. For example, a medication may be effective in one individual, while it makes another even more ill. Until now, we’ve had no way to test
Read More
NIH Awards UCSF Researchers $11.7M Grant to Launch Pediatric Precision Medicine Equity Program
The National Institutes of Health (NIH) has awarded a team of UC San Francisco researchers with a four-year $11.7 million grant to launch a new Prenatal and Pediatric Genomic Sequencing (P3EGS ) program at UCSF, according to UCSF news. Over the four-year span, the program is focused on pursuing equity in the implementation of genomic precision medicine for children and families in the San Francisco Bay Area.As part of the pediatric precision medicine program, the P3EGS team will recruit 1,100
Read More